Senior Director, GMP Quality Assurance

Role Overview & Key Functions:

Purpose: Provide strategic and enterprise-level leadership of GMP Quality and Quality across GxP domains, through oversight of a robust and integrated Quality Management System (QMS). Lead a team of subject matter experts to ensure the design, implementation, and continuous improvement of quality systems that enable compliant clinical development, pharmacovigilance, and manufacturing operations across the product lifecycle.

Strategic Quality Leadership

• Serve as a key member of the Quality Leadership Team, providing strategic direction across GMP Quality and QMS.
• Act as the executive sponsor for Quality Systems, ensuring alignment with corporate strategy and regulatory expectations.
• Present GMP and QMS performance, trends, and risks to executive leadership, including KPIs and health metrics.

Cross-Functional & Enterprise Integration

• Partner with Pharmaceutical Science (CMC), Regulatory IT, and Clinical Quality to ensure QMS integration across GxP domains.
• Collaborate with IT to implement and optimize digital QMS solutions.
• Ensure alignment between vendor quality systems and internal QMS expectations.

Strategic GMP Quality Leadership:

• Strategic leader on the Quality and Compliance Leadership Team to represent the oversight and management of the GMP Quality team to support clinical and commercial manufacturing and supply.
• Provide oversight to and actively manage the GMP Quality Operations team.
• Provide expertise in GMP compliance interpretation, consultation, training, and recommendations.
• Collaborates cross-functionally other functions, such as CMC, Regulatory, Quality Systems, Vendor Management as needed to ensure alignment and best practices.
• Lead the team by planning and developing and attracting talent and ensuring that the team's capabilities meet Karyopharm's core value and future needs.
• Support development opportunities and mentor and coach team members.
• Lead and oversee writing/revising Quality SOP's and performing review and approval of external and internal generated documents/reports (Master Batch Records, Executed BR's, specifications, methods, validation documents, and other GXP Documentation).
• Lead implementation of a robust Vendor Oversight Program for GMP Quality Vendors.
• Ensure generation and maintenance of Quality Technical Agreements with Contract Service Providers.
• Lead and provide oversight into the risk based GMP audit and compliance strategy. Lead the assessment of audit findings and other identified compliance risks to subject safety, data integrity, and business operations and escalate compliance risks to Senior Management. Ensure audit reports and corrective actions are developed and completed within timelines mandated in internal procedures.
• Lead investigations into significant quality issues with focus on product impact and patient safety; escalate and manager MRB (Material Review Board) meetings; facilitate identification of root cause and development of appropriate corrective and preventive actions; track actions and confirm effectiveness; ensure reporting of potential or confirmed violations to regulatory authorities, as appropriate.
• Lead and oversee the GMP Quality Management Reviews (QMRs) as SME to GMP Quality Metrics. Analyze, report, and present metrics to functional teams and Quality management; Identify any risks and recommend any required actions and monitor implementation of mitigation or preventive actions.
• Demonstrated experience leading and hosting GMP audits, including health authority inspections.
• Lead and provide oversight on all Global Partnership/Alliance projects.

Quality Systems (QMS) Leadership:

• Own and lead the end-to-end Quality Management System (QMS), ensuring it is compliant, scalable, and aligned with global regulatory expectations (FDA, EMA, ICH).

• Establish and maintain governance of core QMS elements, including:

• Deviations, CAPA, Change Control

• Document Control and Records Management

• Training and Learning Management Systems

• Complaint handling and product quality reviews (PQR/APR)

• Drive harmonization and standardization of QMS processes across GMP and GxP functions.

• Lead QMS maturity initiatives, including continuous improvement, simplification, and digital transformation (eQMS - Veeva Quality platforms).

• Ensure inspection readiness at all times, including development of global inspection readiness frameworks, playbooks, and mock inspection programs.

• Oversee quality risk management (QRM) processes and ensure integration into QMS decision-making.

• Author, review, and/or approval documents including deviations, SOPs, and protocols.

Audit, Inspection & Compliance

• Oversee global audit and inspection strategy, integrating QMS and GMP compliance.
• In collaboration with other GxP areas, support regulatory inspections (FDA, EMA, global agencies).
• Ensure audit and inspection findings are systematically trended within the QMS to drive systemic improvements.
• Escalate critical compliance risks to executive leadership.

People & Organizational Leadership

• Lead and provide oversight of GMP & QMS teams and facilitate development opportunities and mentor and coach QA team members.
• Build and lead a high-performing GMP and QMS organization.
• Develop future leaders in both operational quality and quality systems disciplines.
• Foster a quality culture focused on compliance, accountability, and continuous improvement.

Candidate Profile & Requirements:

• 15+ years in GxP Quality, with significant leadership experience in both GMP Quality Operations and Quality Systems (QMS).
• In-depth knowledge of other international regulations and guidelines related to GMP projects
• Proven experience designing, implementing, or transforming enterprise QMS frameworks.
• Strong track record with regulatory inspections and global health authority interactions.
• Excellent understanding of the drug development and commercialization process.
• Proven track record of successful management of quality management, quality assurance and/or compliance programs, including participation in audits and/or inspections, and investigating and addressing non-compliance issues.
• Demonstrated leadership skills and experience in managing cross-functional matrixed teams.
• Strong communication and interpersonal skills, capable of effectively collaborating with cross-functional teams and external stakeholders.
• Strong problem-solving and decision-making abilities, with a focus on continuous improvement.
• Experience in leading inspection readiness exercises and supporting health authority inspections is preferred.
• Minimum: BA/BS degree or in a life science discipline. Advanced degree is strongly preferred.
• Relevant certifications are desirable but not mandatory.
• Experience with small molecules is highly preferred.
• Experience in managing, hosting, or supporting FDA, EMA or other regulatory agency inspections.

At Karyopharm, base pay is one part of a competitive total rewards package that includes comprehensive benefits (medical, dental, vision, 401(k), and more), equity and the potential to receive annual target bonuses. Actual pay is based on factors such as location, experience, skills, education, and internal equity. We maintain broad salary ranges to reflect market conditions and the specialized nature of our work. The anticipated base salary range for this position is $275 K - 300 K USD.

Our Value Proposition:

This is a uniquely exciting time to join Karyopharm Therapeutics where we are pioneering the science of nuclear export inhibition to develop differentiated therapies for patients with cancer. We are building upon an established commercial foundation in multiple myeloma while advancing the potential of selinexor across additional hematologic and solid tumor cancers including myelofibrosis and TP53 wild-type endometrial cancer, areas where patients continue to face significant unmet needs.

Our lead therapy, XPOVIO (selinexor), is a first-in-class inhibitor of exportin 1 (XPO1) and is approved in the U.S. for adults with relapsed or refractory multiple myeloma, with approvals in more than 50 countries and territories outside the U.S. We are also exploring opportunities to evaluate XPO1 inhibition across myeloproliferative neoplasms and TP53 wild-type driven solid tumors using next-generation compounds, including eltanexor.

As we prepare for our next phase of growth, we are continuing to invest in critical capabilities across the organization to support future opportunities and deepen our impact in oncology. We are looking for talented people who are motivated by meaningful work, energized by growth and momentum, and excited by the opportunity to help shape what comes next in a collaborative, fast-moving environment where individual contributions are visible and valued.

Learn more at Karyopharm Therapeutics.